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Introduction
Placenta accreta is the abnormal implantation of the
placenta into the myometrium without intervening
decidual cells. In the event of placenta accreta, the third
stage of labor may be complicated by severe uterine
hemorrhage that may lead to the need for extensive
life-saving surgical interventions such as hysterectomy
and ligation of major pelvic vessels.
The approach most often recommended in cases of
placenta accreta is extirpative, namely, hysterectomy
with simultaneous placenta removal. However, a few
successful cases of conservative treatment have been
reported. Conservative management means leaving
the adherent placenta in situ with or without adjuvant
therapy, such as methotrexate injection. The advantages
of a conservative strategy are mainly preserving fertility
and reducing blood loss. However, the risk of delayed
hemorrhage and endometritis cannot be completely
obviated. This paper reports a patient with placenta
accreta treated conservatively but who suffered septic
shock during evacuation of the retained placenta in the
postpartum period. Our experience may assist clinicians
in determining the optimal management for similar
cases.
Case Report
A 39-year-old woman, gravida 2, para 1, presented at
30 weeks’ gestation with vaginal bleeding for 1 week.
She had given birth to one baby by emergency cesarean
section due to prolonged labor. Other history was un-
remarkable. On admission, ultrasonography revealed a
male fetus weighing approximately 1,200 g presenting
in the vertex position. The placenta was located mainly
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in the right posterior wall. Neither placenta lacuna nor
loss of retroplacental echolucency was disclosed by this
scan. Tocometry showed regular uterine contractions
at a frequency of 3/10 minutes. She was admitted and
given intravenous ritodrine infusion for tocolysis. Despite
a high dose of ritodrine and magnesium sulfate supple-
mentation, the irregular uterine contractions persisted.
At 35 weeks of gestation, the estimated fetal weight had
reached 2,200 g. She underwent cesarean section and
delivered a premature male baby weighing 2,346 g,
with Apgar scores of 8 and 9 at 1 and 5 minutes, respec-
tively. After cord clamping, part of the placenta appeared
to be densely adhered to the right fundal wall. Since
the amount of hemorrhage was not tremendous, we de-
cided on a conservative approach. About one-third of
the placenta was left in situ. The edge of the placenta was
ligated with 1-0 vicryl. The myometrium and abdominal
wall were closed as usual. Total surgical blood loss was
about 700 mL and no blood transfusion was needed.
Ultrasonography after cesarean section revealed an 8 ×
8 × 6 cm placenta remaining over the right fundus.
The postpartum course was complicated by tem-
porary fever () 38.6°C) and leukocytosis (white blood
cell count, WBC, 14,720/μL; segment, 88.3%). Blood
culture was negative, but cervical culture yielded Enter-
obacter cloacae. Since fever and leukocytosis subsided
after antibiotic treatment (cefmetazole and gentamycin),
the patient was discharged with oral antibiotics on
postpartum day 4.
After discharge, she was monitored weekly at our
clinic, including pelvic examination, ultrasonography,
and complete blood counts. The recovery course was
complicated by a common cold with acute tonsillitis.
Intermittent fever and chills developed 1 week after
discharge. Despite treatment with oral cephalexin,
leukocytosis (WBC, 13,540/μL; segment, 89.4%) and
high C-reactive protein (10.16 mg/dL) were noted. She
was readmitted on postpartum day 25 for intravenous
antibiotic treatment. Since blood culture showed the
growth of Escherichia coli, parenteral antibiotics were
switched from cefazolin to more sensitive agents in-
cluding cefmetazole and gentamycin. Urine and cervical
cultures also yielded E. coli. The possibility of tonsillitis
as the cause of puerperal fever was excluded.
Despite the fact that antibiotic therapy covered the
spectrum of pathogens, the patient’s fever and leuko-
cytosis remained. Repeated scanning of the uterus
did not reveal abundant perfusion from the uterus to
the placenta. The thinnest myometrium beneath the
placenta was 0.3 cm. Careful dilatation and curettage
was  chosen after discussion with the patient. On post-
partum day 33, the retained placenta was evacuated
piece by piece under ultrasound guidance. The esti-
mated blood loss was about 50 mL. However, sudden
onset of symptoms and signs of septic shock including
tachycardia (162 beats/min), fever (39.1°C) with chills,
hypotension (90/60 mmHg), and warm extremities was
noted 1 hour after dilatation and curettage. Empiric
antibiotics (cefepime, metronidazole, gentamycin) and
fluid challenge via the central venous route were given
at the suggestion of an infection specialist. The patient’s
pulse and blood pressure stabilized 2 hours later. Blood
culture showed the remarkable growth of E. coli 2 days
later. The antibiotics were changed to metronidazole
and cefazolin according to the suggestion of the in-
fection specialist. Fever subsided and vaginal discharge
decreased. The WBC returned to normal. Pathology
showed degenerated fibrotic gestational villi and
trophoblasts with prominent areas of necrosis in mixed
dense inflammatory cells. The patient was discharged
uneventfully on postpartum day 43.
Discussion
Placenta accreta occurs when the placenta directly
adheres to the myometrium without an intervening
decidual and Nitabuch’s layer. The incidence of placenta
accreta is above 1 in 2,500 deliveries [1]. The major
complication of placenta accreta is massive postpartum
hemorrhage that occurs when attempting to remove the
placenta. The hemorrhage is usually so profuse, even
life-threatening, that massive blood transfusions and
emergency hysterectomy are needed to control bleed-
ing and save the mother’s life [2]. Diagnosis prior to
delivery can be achieved from the lack of a sonolucent
area beneath the implantation site of the placenta on
ultrasonography. However, there is no single diagnostic
modality with absolute accuracy. The diagnosis is more
often made when there is difficulty in establishing a
cleavage plane during removal of the placenta. Efforts
to manually remove the adherent placenta usually result
in massive blood loss and even unstable hemodynamic
status.
Traditional management of placenta accreta is
peripartum hysterectomy, especially for massive post-
partum hemorrhage or unstable hemodynamics [3,4].
However, maternal morbidity and even mortality are
still common. Complications include loss of fertility,
massive blood transfusion, ureteral ligation or fistula
formation, infection, perinatal death, and maternal
death [5]. In addition, these operations usually require
the presence of an experienced pelvic surgeon.
On the other hand, successful conservative treat-
ment in women with placenta accreta has been reported
[6–8]. One retrospective study concluded that con-
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servative management of placenta accreta is associated
with a reduction in severe postpartum hemorrhage and
hysterectomy [8]. Conservative management can be
considered in selected cases of women without massive
postpartum hemorrhage who want to preserve fertility.
In general, a conservative strategy leaves the placenta in
situ without forced removal during delivery. Sometimes
adjuvant treatments are given, including methotrexate,
uterine artery embolization, or sulprostone. Prophylactic
antibiotics are usually used to prevent infection. The
benefits of conservative treatment include less post-
partum hemorrhage, decreasing the need for blood
transfusion or hysterectomy, and preservation of
the uterus and further fertility. However, the outcome of
conservative treatment is not always satisfactory [9,
10]. The disadvantages include postpartum infection,
treatment failure, frequent follow-up, and even further
surgical intervention such as hysterectomy [8].
In our patient, advanced maternal age and previous
cesarean section were the only identified risk factors
[11]. The site of placenta implantation was the uterine
fundus, and sonography did not show obvious signs of
possible placenta accreta. The diagnosis was established
when difficulty was encountered in removing the placenta
at cesarean section. Conservative treatment leaving the
placenta in situ was chosen to preserve the uterus and
prevent postpartum hemorrhage. Although there are
several encouraging reports of conservative treatment,
there is still no consensus about an optimal protocol.
One series that compared conservative (leaving the
placenta in situ) and extirpative (leaving the uterine
cavity empty by removing the placenta) strategies for
placenta accreta showed that leaving the placenta
accreta in situ appears to be a safe alternative to removing
it [8]. Success and failure of treatment with metho-
trexate have both been reported, and the role of metho-
trexate is not clear at present. Infection is one disad-
vantage associated with conservative treatment, but
it usually responds to antibiotics, even when there is
sepsis [8]. In our patient, antibiotics were used for
at least 4 weeks to treat postpartum endometritis, but
puerperal fever with leukocytosis persisted. In retained
placenta complicated with persistent postpartum
endometritis in spite of long-term antibiotic treat-
ment, clearance of the possible infectious origin should
be considered. Therefore, dilatation and curettage was
performed to evacuate the retained placenta in order
to improve the outcome. However, septic shock oc-
curred immediately after dilatation and curettage. It is
hard to determine whether dilatation and curettage
aggravated the course of the infection or promoted the
effectiveness of antibiotic therapy. We thought that
antibiotic treatment alone was not sufficient to cure
the endometritis in our patient, and an extirpative
strategy to clear the infectious focus was needed. Perhaps
earlier dilatation and curettage could have prevented
septic shock and led to a better outcome. Conservative
treatment of placenta accreta in selected patients is an
attractive and safe alternative. The strategy of conser-
vative treatment should be individualized and based on
clinical manifestation to prevent morbidity or mortality
until an optimal protocol is developed.
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